Signals, Powered By EquityPandit
Natco Pharma has posted 69.75 percent rise in the consolidated net profit to Rs 47.65 crore for the first quarter ended June 30, 2016.
During the April-June quarter of last fiscal, the company had posted a net profit of Rs 28.07 crore.
Natco Pharma has said in a BSE filing that its consolidated net sales were up 38.02 percent to Rs 297.71 crore during the period under review as against Rs 215.69 crore in the corresponding quarter of previous fiscal.
The company, in a separate filing said that its board in a meeting has recommended payment of an interim dividend of Rs 0.75 on each equity share of Rs 2 each for 2016-17.
